Company: DVAX
Filing Date: 2025-01-29
Form Type: 8-K
Source: 0001193125-25-015683
Chunk: 2

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-01-29
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01. Other Events

Authorized Number of Directors

The Company’s Amended and Restated Bylaws provide that the authorized number of directors shall be fixed by the Board from time to time. To facilitate the appointment of Ms. Silvernail and Dr. Emini to the Board, on January 26, 2025, the Board increased the authorized number of directors to eleven (11), effective as of immediately prior to the appointments of Ms. Silvernail and Dr. Emini. In view of the retirement and resignation of Ms. Phillips and Ms. Eastland immediately prior to the 2025 Annual Meeting, the Board decreased the authorized number of directors to nine (9), effective immediately prior to the 2025 Annual Meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                       Dynavax Technologies Corporation  
  Date: January 29, 2025      By:      /s/ RYAN SPENCER                  
                                       Ryan Spencer                      
                                       Chief Executive Officer